Orphan designation: Pamrevlumab Treatment of Duchenne muscular dystrophy, 16/12/2019 Withdrawn
Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines scientific advice, protocol assistance, qualification of biomarkers and EMA/EUnetHTA parallel consultation requests
Human medicines European public assessment report (EPAR): Ganfort, bimatoprost,timolol, Date of authorisation: 19/05/2006, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Lumigan, bimatoprost, Date of authorisation: 08/03/2002, Revision: 38, Status: Authorised
VICH GL21 Efficacy of anthelmintics: specific recommendations for chickens – gallus gallus (Revision 1)
VICH GL20 Efficacy of anthelmintics: specific recommendations for felines (Revision 1)
VICH GL19 Efficacy of anthelmintics: specific recommendations for canines (Revision 1)
VICH GL16 Efficacy of anthelmintics: specific recommendations for porcines (Revision 1)
VICH GL15 Efficacy of anthelmintics: specific recommendations for equines (Revision 1)
VICH GL14 Efficacy of anthelmintics: specific recommendations for caprines (Revision 1)